435 related articles for article (PubMed ID: 24249219)
21. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
22. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.
Sinn BV; Darb-Esfahani S; Wirtz RM; Budczies J; Sehouli J; Chekerov R; Dietel M; Denkert C
Histopathology; 2011 Nov; 59(5):918-27. PubMed ID: 22092403
[TBL] [Abstract][Full Text] [Related]
24. The expression of intermediate filaments in canine mammary glands and their tumors.
Hellmén E; Lindgren A
Vet Pathol; 1989 Sep; 26(5):420-8. PubMed ID: 2555958
[TBL] [Abstract][Full Text] [Related]
25. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
26. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
28. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
29. Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog.
Marinelli L; Gabai G; Wolfswinkel J; Mol JA
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):167-73. PubMed ID: 15555910
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 expression in canine mammary tumors.
Doré M; Lanthier I; Sirois J
Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
33. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses.
Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC
Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216
[TBL] [Abstract][Full Text] [Related]
34. Mammary cancer in the dog: a study of 120 cases.
Mulligan RM
Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
[TBL] [Abstract][Full Text] [Related]
35. DNA and RNA isolation from canine oncologic formalin-fixed, paraffin-embedded tissues for downstream "-omic" analyses: possible or not?
Granato A; Giantin M; Ariani P; Carminato A; Baratto C; Zorzan E; Vascellari M; Bozzato E; Dacasto M; Mutinelli F
J Vet Diagn Invest; 2014 Jan; 26(1):117-24. PubMed ID: 24398906
[TBL] [Abstract][Full Text] [Related]
36. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
37. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
de Las Mulas JM; Millán Y; Dios R
Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
39. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors.
Lim HY; Im KS; Kim NH; Kim HW; Shin JI; Sur JH
Vet J; 2015 Mar; 203(3):326-31. PubMed ID: 25641553
[TBL] [Abstract][Full Text] [Related]
40. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
